Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5068907
Reference Type
Journal Article
Subtype
Abstract
Title
The association of vanadium pentoxide and inflammatory response in patients with copd and in human bronchial epithelial cell
Author(s)
Lin, SH; Lin, CH; Li, YR; Ching, YY; Chang, HH
Year
2018
Is Peer Reviewed?
1
Journal
Respirology
ISSN:
1323-7799
EISSN:
1440-1843
Volume
23
Issue
Supplement 2
Page Numbers
109, AP052
Language
English
DOI
10.1111/resp.13420_51
Web of Science Id
WOS:000456217200272
Abstract
Background and Aims
Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation. Air pollution is strongly related to chronic obstructive pulmonary disease (COPD). Vanadium (V) is major transition metal often adhered to particulate matter and emitted into the atmosphere as vanadium pentoxide (V2O5) by the combustion of fossil fuels and metallurgic industry activities. Particulate matter (PM) air pollution contributes to inflammation‐related processes including COPD. Our aim is to evaluate the effect of vanadium on the inflammatory response in vitro and in patients with COPD.
Methods
The expression of proinflammatory cytokine and chemokine mRNA analyzed by real‐time PCR. Reactive oxygen species (ROS) level determined by flow cytometry using DCF‐DA staining. Cytometric bead‐based assays were used to quantify inflammatory cytokines in the culture media and the plasma of healthy and COPD subjects. p‐ERK and p‐JNK expression were performed by western blot. Statistical analyses were performed using unpaired t‐test at P < 0.05 with GraphPad Prism version.
Results
Our finding identified a positive relationship between the concentration of vanadium in urine and the expression of inflammatory factor (IL‐8, MCP‐1) in plasma of patients with COPD. Moreover, V2O5 induces IL‐8, MCP‐1, IP‐10 and CXCL‐11 mRNA expression and increase ROS production in BEAS‐2B human bronchial epithelial cell. Treatment with N‐acetylcysteine protects against V2O5‐stimulated ROS production and down‐regulation of IL‐8, MCP‐1, IP‐10 and CXCL‐11 mRNA expression in BEAS‐2B cells. MAPK pathways are typically involved in inflammation. V2O5 treatment increase p‐ERK and p‐JNK expression in BEAS‐2B stimulated with V2O5.
Conclusion
Our finding demonstrate that inflammatory response in patient with COPD is associated with vanadium, a usually component of particulate matter. And V2O5 induce excessive inflammation through activating MAPK mediated oxidative stress signalling in BEAS‐2B human bronchial epithelial cell. These evidence show that vanadium and its oxidant may contribute to chronic inflammation in patient with COPD.
Conference Name
23rd Congress of the Asian Pacific Society of Respirology
Conference Location
Taipei, Taiwan
Conference Dates
29 November–2 December 2018
Tags
IRIS
•
Vanadium Compounds - Oral
Literature Search: Jan 2010 - Mar 2019
WoS
Combined data set
Dataset for title/abstract screening
Dataset for full text screening
Supplemental (full text)
Supplemental material
Abstract only
•
Vanadium Inhalation
Literature Search: Jan 2010 – Mar 2019
WoS
Combined Dataset
Dataset for title/abstract screening
Dataset for full text screening
Supplemental (full text)
Supplemental material
Conference abstract
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity